Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2661503 | 1.00 | CA2 (0.35) | CA2 | |
| SCHEMBL2661501 | 1.00 | CA2 (0.35) | CA2 | |
| SCHEMBL2658122 | 0.83 | PABPC1 (0.31) | CA2 | |
| SCHEMBL17189790 | 0.83 | PABPC1 (0.31) | CA2 | |
| SCHEMBL15690321 | 0.83 | PABPC1 (0.31) | CA2 | |
| SCHEMBL15690638 | 0.83 | PABPC1 (0.31) | CA2 | |
| SCHEMBL15690640 | 0.83 | PABPC1 (0.31) | CA2 | |
| SCHEMBL2658124 | 0.83 | PABPC1 (0.31) | CA2 | |
| SCHEMBL16727652 | 0.73 | CA2 (0.32) | CA2 | |
| SCHEMBL16727647 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160221985-A1 | METHOD FOR THE PREPARATION OF THIADIAZOLES | BERCOT ERIC A (US) | 2016-08-04 | — | — | US | disclosed |
| US-9296735-B2 | Method for the preparation of thiadiazoles | AMGEN INC. (US) | 2016-03-29 | — | — | US | disclosed |
| US-20150141655-A1 | METHOD FOR THE PREPARATION OF THIADIAZOLES | AMGEN INC. | 2015-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141655-A1 | METHOD FOR THE PREPARATION OF THIADIAZOLES | GAPDH, TALDO1, HOGA1 | CA2 3620/4885 |
| US-20160221985-A1 | METHOD FOR THE PREPARATION OF THIADIAZOLES | GAPDH, TALDO1, HOGA1 | CA2 3620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.